Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden - The Lancet
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months | NEJM
Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India | Nature Medicine
Preliminary Data Analysis: Effectiveness of the Fourth Dose for Older Adults 60 Years of Age and Older | Ministry of Health
Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose | NEJM
Israeli Hospital Studies Effects of a Fourth Dose of the Covid-19 Vaccine - The New York Times
Israeli trial, world's first, finds 4th dose 'not good enough' against Omicron | The Times of Israel
mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar | Nature Medicine
Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden - The Lancet
Boosting immunity to Omicron | Nature Medicine
ATAGI statement on recommendations on a winter booster dose of COVID-19 vaccine | Australian Government Department of Health and Aged Care
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine - ScienceDirect
Two doses prevent about 95 per cent of COVID-19 hospitalizations: B.C. COVID-19 vaccine effectiveness results
Protection by 4th dose of BNT162b2 against Omicron in Israel
Nursing home study shows 4th COVID mRNA dose provides extra protection against severe Omicron outcomes
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study | The BMJ
A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain | Nature Communications
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting | NEJM
4th COVID-19 vaccine dose less effective against Omicron, Israel study shows - National | Globalnews.ca
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine | NEJM
Most Immunocompromised People Have Gotten the 4th COVID-19 Vaccine Dose
Effectiveness of the Fourth Dose Against COVID-19: New Data | Psychology Today
How China's Sinovac compares with BioNTech's mRNA vaccine | The Economist
